Epilepsy Surgery Market Poised for Steady Growth Driven by Advancements in Surgical Procedures and Rising Prevalence of Epilepsy.Pune, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Epilepsy Surgery Market Size & ...

Three-year targets of 20% revenue CAGR and achievement of cash flow breakeven - MOUNTAIN VIEW, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company ...

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

One of the key developments is the potential expansion of indications for the RNS System. NeuroPace is targeting the treatment of idiopathic generalized epilepsy (IGE), with plans to submit an FDA ...

J Epilepsy Res. 2018;8(1):1-5. doi:10.14581/jer.18001 Epilepsy Foundation. Vagus nerve stimulation (VNS) therapy. Epilepsy Foundation. Responsive neurostimulation (RNS). Epilepsy Foundation. FDA ...

including approximately $11 million in stock-based compensation Management also outlined its long-range plan of becoming the recognized leader in drug-resistant epilepsy therapy and fully develop the ...